Daily non-political popular news in brief.

Clot-dissolving agent may be beneficial in treatment of severe frostbite

A preliminary study suggests that a blood clot-dissolving medication that is administered to some patients following a stroke or heart attack may help to reduce the risk of amputation following severe frostbite, according to a report in the June issue of Archives of Surgery, one of the JAMA/Archives journals.

Read more »

Keywords: clot-dissolving, agent, beneficial, treatment, severe, frostbite, clot, dissolving

« Previous | Next »

Similar news on "Clot-dissolving agent may be beneficial in treatment of severe frostbite":

1. New therapy effectively treats deep vein thrombosis
   01-29-2008 · EurekAlert!
   A novel treatment for blood clots in the legs appears to be safe and effective, according to a pilot study. The study found that injecting or "lacing" the clot with a fiber-binding thrombolytic agent effectively treats deep vein thrombosis and reduces the risk of subsequent recurrence or bleeding.
   Similar news · Read more »
   
2. Novel gallium compound may offer treatment for lymphoma patients with resistant disease
   12-11-2006 · EurekAlert!
   Christopher Chitambar, M.D., a physician researcher at the Medical College of Wisconsin Cancer Center in Milwaukee, has identified a compound that may be effective in treating forms of non-Hodgkin's lymphoma (a cancer of the lymphatic system) that are resistant to certain therapies. The new agent could also offer the advantages of being administered orally, rather than intravenously, making it more convenient than intravenous agents.
   Similar news · Read more »
   
3. Finnish scientists discovered a new approach to treat virus-induced lymphomas
   03-15-2007 · EurekAlert!
   Kaposi's sarcoma herpesvirus (KSHV) is a human tumor virus and an etiological agent for Kaposi’s sarcoma and primary effusion lymphoma (PEL). PELs are aggressive lymphomas with reported median survival time shorter than six months after diagnosis. Researchers at the University of Helsinki have discovered that activation of the p53 pathway offers a novel effective treatment modality for KSHV-infected lymphomas.
   Similar news · Read more »
   
4. Late angioplasty after heart attack no better than drug therapy
   11-14-2006 · EurekAlert!
   About one-third of heart attack patients do not receive treatment to open blocked arteries within the recommended 12-hours after a heart attack. For years it has been thought that late balloon angioplasty of these patients' arteries, if they are totally blocked, is still beneficial. However, a large clinical trial found that stable patients who had angioplasty plus stenting three to 28 days after a heart attack did no better than patients on drug treatment alone.
   Similar news · Read more »
   
5. Men more likely to benefit from clot-busting stroke treatment
   03-12-2007 · EurekAlert!
   Men are more likely than women to benefit from the use of a clot-busting drug after stroke, according to a study published in the March 13, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
   Similar news · Read more »
   
6. Study examines treatment of blockages in patients suffering severe heart attacks
   03-25-2007 · EurekAlert!
   Severe heart attacks are often treated with nonsurgical procedures that open narrowed or blocked arteries of the heart using stents (percutaneous coronary intervention, or PCI). A study presented at the American College of Cardiology’s Innovation in Intervention: i2 Summit explores the use of a device positioned just beyond the blockage to catch debris and prevent them from lodging in another downstream blood vessel during PCI to treat patients who suffer from a major heart attack.
   Similar news · Read more »
   
7. Researchers begin randomized double-blind trial of airway bypass treatment for emphysema
   05-17-2007 · EurekAlert!
   Broncus Technologies Inc., today announced the start of its EASE (Exhale Airway Stents for Emphysema) Trial to explore an investigational procedure that may offer a new, minimally-invasive treatment option for millions of emphysema sufferers. The study focuses on a procedure called airway bypass that uses drug-eluting stents to reinforce new pathways in the lung for trapped air to escape. This in turn, may relieve severe emphysema symptoms such as shortness of breath.
   Similar news · Read more »
   
8. New study reveals gender disparity in anti-TNF treatment for rheumatoid arthritis
   06-14-2007 · EurekAlert!
   Findings reported today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain, reveal a treatment disparity between female and male patients with rheumatoid arthritis. Data from a study at the Karolinska Institute, Sweden, show that women receive anti-TNFs -- very effective but expensive modern medications against this disease -- at a higher perceived level of disease activity, and when they are reporting more severe pain than their male counterparts.
   Similar news · Read more »
   
9. Severe asthma may be a different form of the disease
   01-29-2008 · EurekAlert!
   A multi-center research project to investigate severe asthma has found a key physiological difference between severe and non-severe forms of the disease, a finding that could help explain why those with severe asthma do not respond well to treatment. The study from the Severe Asthma Research Program has found that those with severe asthma are much more likely to show signs of "air trapping" in the lungs, a condition that prevents a full exhalation.
   Similar news · Read more »
   
10. Positive clinical trial results of investigational thrombocytopenia agent
    12-12-2006 · EurekAlert!
    At the American Society of Hematology meeting in Orlando AkaRx, Inc. presented the positive results from two Phase I studies of AKR-501, an investigational compound for the treatment of thrombocytopenia.
    Similar news · Read more »